Last edition
News about Engineering
FDA Approves New Therapy for Dravet Syndrome
The U.S. Food and Drug Administration today approved Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older. Dravet syndrome is a life-threatening, rare and chronic form of epilepsy. It is often characterized by severe and unrelenting seizures
Engineering | 29/06/2020 | By Darshana | 443
today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with automated assessments of scanned slide images that are objective and reproducible and have the potential to aid diagnosis
Engineering | 26/06/2020 | By Darshana | 334
Cipla launches generic remdesivir for COVID-19
Cipla Limited announced the launch of generic version of remdesivir under its brand name Cipremi. The US FDA issued an emergency use authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients
Engineering | 22/06/2020 | By Darshana | 312
Glenmark Pharma launches favipiravir drug for COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has launched antiviral drug favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients
Engineering | 22/06/2020 | By Darshana | 375
On the lines of the medical apps being used by healthcare professionals and chronic patients to avail information on medicines and doctors' services, the pharmaceutical manufacturing companies worldwide have started launching Pharma Apps to educate doctors and hospital administrators about new drugs
Engineering | 16/06/2020 | By Darshana | 347
The COVID19 pandemic has so far affected 216 countries and caused more than 59.31 lakh cases and 3.65 lakh deaths worldwide
Engineering | 02/06/2020 | By Darshana | 317
FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
Today, the U.S. Food and Drug Administration took important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance with recommendations for innovators and researchers conducting work in this area
Engineering | 12/05/2020 | By Darshana | 308
Aurobindo Pharma receives US FDA approval for generic Ancobon capsules
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (FDA) to manufacture and market flucytosine capsules, 250 mg and 500 mg
Engineering | 04/05/2020 | By Darshana | 723
These new analyses add additional evidence to the benefit-risk profile of OCREVUS, including the impact of MS on people's daily lives. The data were selected for the 72nd American Academy of Neurology (AAN) Annual Meeting and will be made available online via virtual presentation in the coming weeks
Engineering | 30/04/2020 | By Darshana | 212
Dr Reddy's Labs launches generic NitroDur in US market
Dr Reddy's Laboratories Ltd announced the launch of authorized generic version of NitroDur (nitroglycerin) transdermal infusion system
Engineering | 15/04/2020 | By Darshana | 281
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy